Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nassima Ait-Daoud

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Drug and Alcohol Dependence|November 13, 2012
Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysisJennie Z Ma, Bankole A Johnson, Elmer Yu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceMegan L Ryan, Daniel E Falk, Joanne B Fertig, et al.
Addiction (Abingdon, England)|January 7, 2012
Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trialAhmed Elkashef, Roberta Kahn, Elmer Yu, et al.
Alcoholism, Clinical and Experimental Research|November 8, 2018
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and SafetyDaniel E Falk, Megan L Ryan, Joanne B Fertig, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Drug and Alcohol Dependence|November 13, 2012
Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysisJennie Z Ma, Bankole A Johnson, Elmer Yu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceMegan L Ryan, Daniel E Falk, Joanne B Fertig, et al.
Addiction (Abingdon, England)|January 7, 2012
Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trialAhmed Elkashef, Roberta Kahn, Elmer Yu, et al.
Alcoholism, Clinical and Experimental Research|November 8, 2018
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and SafetyDaniel E Falk, Megan L Ryan, Joanne B Fertig, et al.
Pageof 9